Loading organizations...
§ Private Profile · Waltham, MA, USA
Pharmaceuticals focused on treating diabetic and peripheral neuropathies.
Regenacy Pharmaceuticals has raised $39.3M across 2 funding rounds.
Regenacy Pharmaceuticals has raised $39.3M in total across 2 funding rounds.
Regenacy Pharmaceuticals has raised $39.3M across 2 funding rounds. Most recently, it raised $9.3M Series B in August 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 24, 2022 | $9.3M Series B | Todd Kaloudis | 3E Bioventures Capital, Yonjin Capital | Announced |
| Mar 25, 2020 | $30M Series A | Marc Cohen | Frank YAN, Taya Ventures, Daguan Wang | Announced |
Regenacy Pharmaceuticals has raised $39.3M in total across 2 funding rounds.
Regenacy Pharmaceuticals's investors include Todd Kaloudis, 3E Bioventures Capital, Yonjin Capital, Marc Cohen, Frank Yan, Taya Ventures, Daguan Wang.